Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: CAExchange: Nasdaq
DilutionScan read 31 of XORTX Therapeutics Inc.'s SEC filings and found 15 warrant series, 1 ATM program, 1 shelf registration, 2 S-1 registrations and 3 completed offerings on file for XRTX. The latest dilution event on file is an offering on May 19, 2026. Analysis updated Oct 4, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
MLECMoolec Science SA Ordinary Shares
GNPXGenprex, Inc.
GOVXGeoVax Labs, Inc.
PPCBPropanc Biopharma, Inc. Common Stock
ELABPMGC Holdings Inc.
PPBTPurple Biotech Ltd. American Depositary Shares
OGENOragenics, Inc.
KPTIKaryopharm Therapeutics Inc.
KAPAKairos Pharma, Ltd.
BRTXBioRestorative Therapies, Inc.
SLXNSilexion Therapeutics Corp Ordinary Shares
ENLVEnlivex Ltd. Ordinary Shares
VRAXVirax Biolabs Group Limited Ordinary Shares
VIVSVivoSim Labs, Inc.
SILOSilo Pharma, Inc.